drugset / Trial / NCT03473197

A 6-Week Study to Evaluate the Photoallergic Potential of Diacerein 1% Ointment in Healthy Volunteers

NCT03473197

Phase 1 Completed 61 enrolled Castle Creek Pharmaceuticals, LLC
NaSingle-groupOpen-labelPrevention

Summary

A study in healthy male and female adult volunteers to determine the potential of diacerein 1% ointment to induce a photoallergic skin reaction using a controlled photopatch testing procedure.

Timeline

Start
2018-01-08
Primary completion
2018-03-09
Completion
2018-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diacerein Small molecule 1 % Topical

Indications

No indication recorded.